Natalie Berner

Natalie Berner is a Managing Director and Partner at Redmile Group, specializing in therapeutics. She leverages a strong scientific background, including a pre-medical sciences certificate from Columbia University and previous experience as a research associate at NYU School of Medicine. She serves as a Non-Executive Director on the boards of multiple biotechnology companies, including BioInvent, Redx Pharma, and Sensorion.

Her academic foundation in community health from Brown University and extensive experience in clinical research settings underscore a deep-seated interest in advancing medical science and public health. This blend of scientific inquiry and strategic investment highlights her commitment to the healthcare sector from multiple professional angles.

She transitioned from a hands-on scientific research and pre-med track into healthcare investment, where she now guides the growth of therapeutics companies.